PROTAGONIST THERAPEUTICS INC's ticker is and the CUSIP is 4366E1029. A total of 1 filers reported holding PROTAGONIST THERAPEUTICS INC in Q3 2019. The put-call ratio across all filers is - and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2019 | $24,876,000 | -0.8% | 2,071,297 | 0.0% | 0.67% | +16.3% |
| Q2 2019 | $25,083,000 | -3.7% | 2,071,297 | 0.0% | 0.58% | -21.6% |
| Q1 2019 | $26,036,000 | +183.3% | 2,071,297 | +51.7% | 0.74% | +110.0% |
| Q4 2018 | $9,190,000 | -16.2% | 1,365,579 | +28.1% | 0.35% | +19.5% |
| Q3 2018 | $10,973,000 | – | 1,066,415 | – | 0.29% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Perceptive Advisors | 2,071,297 | $24,876,000 | 0.67% |